Abstract | BACKGROUND: METHODS: The effect of concomitant treatment with a PPARα agonist on retinoid dermatitis in hairless mouse epidermis was evaluated by measuring transepidermal water loss, epidermal histology, and cytokine expression. RESULTS: CONCLUSIONS: Our results indicate that PPARα agonists can potentially be used to improve retinoid dermatitis. We suggest that co-treatment with retinyl retinoate and a PPARα agonist may reduce or prevent detrimental alterations in retinoid-treated skin.
|
Authors | Bora Kim, Jin E Kim, Hyuk Kim, Joo D Lee, Kang-Yell Choi, Seung H Lee |
Journal | International journal of dermatology
(Int J Dermatol)
Vol. 51
Issue 6
Pg. 733-41
(Jun 2012)
ISSN: 1365-4632 [Electronic] England |
PMID | 22607296
(Publication Type: Journal Article)
|
Copyright | © 2012 The International Society of Dermatology. |
Chemical References |
- Enzyme Inhibitors
- Interleukin-1alpha
- Interleukin-8
- Keratolytic Agents
- Liver X Receptors
- Orphan Nuclear Receptors
- PPAR alpha
- Pyrimidines
- RNA, Messenger
- Retinoids
- Retinyl Esters
- Tumor Necrosis Factor-alpha
- Palmitic Acid
- Tretinoin
- retinyl retinoate
- pirinixic acid
|
Topics |
- Administration, Topical
- Animals
- Cell Differentiation
- Cell Proliferation
- Dermatitis
(drug therapy, pathology)
- Enzyme Inhibitors
(pharmacology)
- Epidermis
(pathology)
- Female
- Interleukin-1alpha
(genetics, metabolism)
- Interleukin-8
(genetics, metabolism)
- Keratolytic Agents
(adverse effects)
- Liver X Receptors
- Mice
- Mice, Hairless
- Orphan Nuclear Receptors
(agonists)
- PPAR alpha
(agonists)
- Palmitic Acid
(pharmacology)
- Pyrimidines
(pharmacology)
- RNA, Messenger
(metabolism)
- Retinoids
(adverse effects)
- Retinyl Esters
- Tretinoin
(adverse effects)
- Tumor Necrosis Factor-alpha
(genetics, metabolism)
- Water Loss, Insensible
|